Use of Antipsychotic Drugs During Pregnancy.
Curr Treat Options Psychiatry
; 6(1): 17-31, 2019 Mar.
Article
en En
| MEDLINE
| ID: mdl-32775146
ABSTRACT
PURPOSE OF REVIEW Antipsychotics are frequently prescribed to women of childbearing age and are increasingly prescribed during pregnancy. A small, but growing, body of research on implications for pregnancy and infant outcomes is available to inform the risks and benefits of in utero exposure to antipsychotics. This review examines the existing published research on the use of common typical and atypical antipsychotics in pregnancy and the implications for pregnancy and infant outcomes. RECENT FINDINGS:
The majority of studies do not show associations with major malformations and antipsychotic use in pregnancy, with the possible exception of risperidone. There is concern that atypical antipsychotics may be associated with gestational diabetes. Metabolic changes during pregnancy may necessitate dose adjustments.SUMMARY:
In general, it is recommended that women who need to take an antipsychotic during pregnancy continue the antipsychotic that has been most effective for symptom remission. Further study on risperidone is needed to better understand its association with malformations and it is not considered a first-line agent for use during pregnancy.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Curr Treat Options Psychiatry
Año:
2019
Tipo del documento:
Article
País de afiliación:
Estados Unidos